A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of Inactivated Vzv Vaccine (ZVIN) in Recipients of Autologous Hematopoietic Cell Transplants (Auto-Hcts)

被引：0

作者：

Winston, Drew J. ^{[1
]}

Mullane, Kathleen M. ^{[2
]}

Boeckh, Michael J. ^{[3
]}

Cornely, Oliver A. ^{[4
]}

Hurtado, Kimberly ^{[5
]}

Su, Shu-Chih ^{[5
]}

Pang, Lei ^{[5
]}

Zhao, Yanli ^{[5
]}

Chan, Ivan S. F. ^{[5
]}

Stek, Jon E. ^{[5
]}

Kaplan, Susan S. ^{[5
]}

Parrino, Janie ^{[5
]}

Annunziato, Paula ^{[5
]}

Popmihajlov, Zoran ^{[5
]}

Arvin, Ann ^{[6
]}

机构：

[1] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA USA

[2] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

[3] Univ Washington, Sch Med, Seattle, WA USA

[4] Univ Cologne, Cologne, Germany

[5] Merck & Co Inc, Kenilworth, NJ USA

[6] Stanford Univ, Sch Med, Stanford, CA 94305 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S22 / S23

页数：2

共 50 条

[1] A phase III, double-blind, randomized, placebo-controlled, multicenter clinical trial to study the safety, tolerability, efficacy, and immunogenicity of inactivated VZV vaccine (ZVIN) in recipients of autologous hematopoietic stem cell transplants (auto-HSCT)
Cornely, O. A.
Winston, D. J.
Mullane, K. M.
Boeckh, M. J.
Hurtado, K.
Su, S. C.
Pang, L.
Zhao, Y.
Chan, I. S. F.
Stek, J. E.
Kaplan, S. S.
Parrino, J.
Annunziato, P. W.
Popmihajlov, Z.
Arvin, A.
BONE MARROW TRANSPLANTATION, 2017, 52 : S17 - S17
[2] Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants A Randomized Double-Blind Placebo-Controlled Study
Englund, Janet A.
Walter, Emmanuel
Black, Steven
Blatter, Mark
Nyberg, Jack
Ruben, Frederick L.
Decker, Michael D.
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (02) : 105 - 110
[3] The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Dakin, Paula
DiMartino, Stephen J.
Gao, Haitao
Maloney, Jennifer
Kivitz, Alan J.
Schnitzer, Thomas J.
Stahl, Neil
Yancopoulos, George D.
Geba, Gregory P.
ARTHRITIS & RHEUMATOLOGY, 2019, 71 (11) : 1824 - 1834
[4] Efficacy and safety of pentavalent rotavirus vaccine in Japan A randomized, double-blind, placebo-controlled, multicenter trial
Iwata, Satoshi
Nakata, Shuji
Ukae, Susumu
Koizumi, Yoshitugu
Morita, Yasuyuki
Kuroki, Haruo
Tanaka, Yoshiyuki
Shizuya, Toshiyuki
Schoedel, Florian
Brown, Michelle L.
Lawrence, Jody
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (08) : 1626 - 1633
[5] Efficacy, Tolerability, and Immunogenicity of OnabotulinumtoxinA in a Randomized, Double-Blind, Placebo-Controlled Trial for Cervical Dystonia
Charles, David
Brashear, Allison
Hauser, Robert A.
Li, Hung-Ir
Boo, Lee-Ming
Brin, Mitchell F.
CLINICAL NEUROPHARMACOLOGY, 2012, 35 (05) : 208 - 214
[6] Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine
Tauber, E.
Kollaritsch, H.
von Sonnenburg, F.
Lademann, M.
Jilma, B.
Firbas, C.
Jelinek, T.
Beckett, C.
Knobloch, J.
McBride, W. J. H.
Schuller, E.
Kaltenboeck, A.
Sun, W.
Lyons, A.
JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (04): : 493 - 499
[7] Efficacy and immunogenicity of inactivated influenza vaccine in pregnant women: A randomized, double-blind, placebo controlled trial
Madhi, S.
Cutland, C.
Hugo, A.
Jones, S.
Kuwanda, L.
Dighero, B.
Treurnicht, F. K.
Klugman, K.
Venter, M.
Simoes, E. A. F.
Neuzil, K.
Ortiz, J.
Weinberg, A.
Nunes, M. S. C.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 430 - 431
[8] THE SAFETY AND TOLERABILITY OF LACOSAMIDE IN RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II/III CLINICAL TRIALS
Gil-Nagel, A.
Biton, V.
Fountain, N.
Rosenow, F.
Hebert, D.
Doty, P.
EPILEPSIA, 2009, 50 : 110 - 110
[9] Efficacy, immunogenicity and safety of CoronaVac® in children and adolescents aged 6 months to 17 years: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial
Xin, Qianqian
Wang, Kaiqin
Toh, Teck-Hock
Yuan, Yue
Meng, Xing
Jiang, Zhiwei
Zhang, Hengming
Yang, Jinye
Yang, Huijie
Zeng, Gang
NATURE COMMUNICATIONS, 2024, 15 (01)
[10] A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial
Akova, Murat
Unal, Serhat
TRIALS, 2021, 22 (01)

← 1 2 3 4 5 →